MAUI, an ultrasound imaging company, announced that it has been awarded a $4 million contract by the U.S. Army Medical Research and Development Command to use autonomous ultrasound technology to support trauma care across four branches of the U.S. military.
The Arizona-based company The MAUI K3900 is 510(k) Clearance “Dr. PETRONAS,” launched in October, is a remote ultrasound imaging diagnostic system for medical professionals in the medical fields of pediatrics, fetal medicine, abdominal medicine, peripheral vascular medicine, adult head medicine, urology, small organ medicine, neonatal head medicine, adult and pediatric cardiology, intraoperative medicine, musculoskeletal medicine, and urology.
“With the U.S. Military contract and our technology coming to the broader stage, we decided it was time to come out of stealth and show people what we’ve been working on,” David Specht, CEO and co-founder of MAUI Imaging, said in a statement.
“The feedback we’ve received from physicians and engineers has highlighted a deep need for new ultrasound-based technologies that allow imaging of all kinds of tissues. That need is most pronounced in trauma medicine and is a major focus of MAUI’s collaborative development efforts. Going forward, MAUI will be able to provide volumetric imaging data for AI tools that are derived primarily from CT and MRI.”
Larger trends
Other companies offering remote imaging technology include digital ultrasound companies. Butterfly Network, a maker of handheld ultrasound systems that connect to smartphones.
Butterfly in January FDA 510(k) Clearance For the company’s third-generation ultrasound system, Butterfly IQ3.
Butterfly iQ3 is a point-of-care ultrasound system that can capture full-body images using a single probe. Once a healthcare professional scans a patient, Butterfly’s software, available for iOS and Android, uses AI and data processing to analyze the images.
Two months later, the company The Butterfly IQ+ ultrasound system has received EU MDR certification, enabling it to be launched into the European market.
In April, Butterfly announced a partnership with an AI ultrasound company. ThinkSono will enable Butterfly users to leverage ThinkSono’s AI training application for Deep Vein Thrombosis (DVT).
In the same month, Clarius Mobile Health, a provider of mobile ultrasound technology, announced it has partnered with ThinkSono to develop a new app called “ThinkSono Guidance,” an AI-enabled application that works with Clarius scanners to improve the detection of DVT.
